Effect of Metformin on Lactate Metabolism in Normal Hepatocytes under High Glucose Stress in Vitro
Objective To study the effect of metformin on lactate metabolism in hepatocytes in vitro under high glucose stress. In vitro LO2 cells, liver cells were randomly divided into blank control group, 25 tendency/L glucose solution, 27 tendency/L glucose solution,29 tendency/L glucose solution, 31 tendency/L glucose solution, 33 tendency/L glucose solution,35 tendency/L glucose solution treatment group, the optimal concentration of 31 tendency after L, use 30 tendency for L metformin solution, and then divided into blank control group, the optimal concentration of glucose solution, normal liver cells + metformin solution normal liver cells. The optimal concentration of glucose solution normal liver cells + metformin solution respectively in the 12 h, 24 h,48 h on cell count plate to calculate the number of liver cells, and using lactic acid determination kit the optimal concentration of glucose solution + normal liver cells and normal liver cells + the optimal concentration of glucose solution + metformin solution respectively in the 12 h, 24 h, 48 h of cell cultures of lactic acid value. There was no significant change in the lactic acid concentration but significant increase in the number of surviving hepatocytes in the highglycemic control group compared with that in the high-glycemic control group without metformin. Metformin has no significant effect on lactic acid metabolism of hepatocytes under high glucose stress in vitro, and has a protective effect on hepatocytes under high glucose stress. Based on this,it is preliminarily believed that metformin is not the direct factor leading to diabetic lactic acidosis.
Keywords:Metformin, Liver cells, Metformin associated lactic acidosis (MALA)
 Mu Yiming, Ji Linong et al. Expert consensus on clinical application of metformin (2016 edition) [J].Chinese Journal of Diabetes, 2016,24 (10) :871-884.
 Dang Yongyan, Ye Xiyun, Shen Jie. Journal of East China Normal University, 2010, (5) : 143-148.(in Chinese with English abstract)
 Su Hongwei, Wei Xun, Pan Hailin et al. Blood Lactic Acid Level and Its Influential Factors in Patients with Type 2 Diabetes [J]. Diabetes mellitus, 2015,32 (2):215-218.
 NingGuang. The status and prospect of diabetes prevention and treatment in China [J]. Science China(Life Sciences), 2018,48 (8) : 810-811.
 Lilian Beatriz Aguayo Rojas,Marilia Brito Gomes.Metformin: an old but still the best treatment for type 2 diabetes[J]. Lilian Beatriz Aguayo Rojas;Marilia Brito Gomes,2013,5(1).
 Zhang Weina, Yu Min, Sun Meiyun, et al. Lactic acidosis caused by metformin: a case report [J].China Rural Medicine 2020,27(01),43-44.
 Qiu Y P. Be careful to take metformin in special population [J]. Shanghai Journal of Traditional Chinese Medicine 2019-08-09 004 Medication guidelines.
 Lin Jian, Zhou Zhiguang. Diagnosis, treatment and progress of diabetic lactic acidosis. Journal of Clinical Internal Medicine, 2017, 34:159-161.
 Richy FF，Sabido-Espin M，Guedes S，et al． Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study．Diabetes Care，2014，37(8) : 2291-2295．
 Aharaz A，Pottegard A，Henriksen DP，et al．Ｒ isk of lactic aci- dosis in type 2 diabetes patients using metformin: A case control study． PloS One，2018，13(5) : e0196122．
 Xianbin Cai,Xi Hu,Bozhi Cai,et al．Metformin suppresses hepatocellular carcinoma cell growth through inductionof cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregu lationof cyclin D1 in vitro and in vivo[J]. Oncology Reports,2013,30(5).
 Guo Yali, Lu Shuming, Li Chunyan, Liu Lina. The relationship between insulin resistance and liver function in patients with cirrhosis and diabetes mellitus [J]. Journal of Dalian Medical University,2017,39(04):378-382.
 Almirall J, Briculle M, Gonzalez clemente JM. Metformin-as-sociated lactic acidosis in type 2 diabetes mellitus : incidence and presentation in common elinical practice. Nephrol Dial Trans-plant ,2008 ,23:2436- 2438.
 Lu ZQ. The value of metguanidine hypoglycemic drugs in the treatment of type 2 diabetes mellitus [J].Journal of Clinical Therapeutics,2010,8(04):33-38.
 McAlister FA, Majumdar SR, Eurich DT et al.The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus:population based cohort study [J].Qual Saf Health Care,2007,16 ( 1) : 6 － 11．
 Tao Wenyu, Chen Jiaoli, Li Xiaojin, Xiong Yuxin,Hong Chao, Wang Xiaoling. Journal of Applied Medicine,2019,35(14):2220-2224+2229.
 LI Yan-chen, HUANG Cai-bin, LIU Yao, XIA Wenyan, XU Rong. The role and mechanism of high mobility group protein B1 in human hepatocyte malignant transformation induced by high glucose microenvironment [J]. Chinese Journal of Diabetes,2019,27(02):137-142.
 Li Z, Ding Q, Ling LP, et al.Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating amp-activated protein kinase[J].World J Gastroenterol, 2018, 24 (7) :819-832